These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 20974253

  • 1. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS, Gaber M, Hussein MM, Ebeid el-ZM.
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [Abstract] [Full Text] [Related]

  • 2. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery.
    Sousa A, Souza KC, Sousa EM.
    Acta Biomater; 2008 May; 4(3):671-9. PubMed ID: 18206431
    [Abstract] [Full Text] [Related]

  • 3. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y, Sun L, Jiang T, Zhang J, Zhang C, Sun C, Deng Y, Sun J, Wang S.
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [Abstract] [Full Text] [Related]

  • 4. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
    Niu N, He F, Ma P, Gai S, Yang G, Qu F, Wang Y, Xu J, Yang P.
    ACS Appl Mater Interfaces; 2014 Mar 12; 6(5):3250-62. PubMed ID: 24521281
    [Abstract] [Full Text] [Related]

  • 5. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W, Xin C, Hui X, Li-Li Z, Jing H, Mei-Juan Z, Jie L, Yi L, Jin-Wen L, Wei Z, Gang C.
    Int J Pharm; 2013 Sep 15; 454(1):135-42. PubMed ID: 23871738
    [Abstract] [Full Text] [Related]

  • 6. Mesostructured silica and aluminosilicate carriers for oxytetracycline delivery systems.
    Berger D, Nastase S, Mitran RA, Petrescu M, Vasile E, Matei C, Negreanu-Pirjol T.
    Int J Pharm; 2016 Aug 30; 510(2):524-31. PubMed ID: 26861688
    [Abstract] [Full Text] [Related]

  • 7. Controlling drug release from mesoporous silica through an amorphous, nanoconfined 1-tetradecanol layer.
    Mitran RA, Matei C, Berger D, Băjenaru L, Moisescu MG.
    Eur J Pharm Biopharm; 2018 Jun 30; 127():318-325. PubMed ID: 29524598
    [Abstract] [Full Text] [Related]

  • 8. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
    Vadia N, Rajput S.
    Eur J Pharm Sci; 2012 Jan 23; 45(1-2):8-18. PubMed ID: 22067974
    [Abstract] [Full Text] [Related]

  • 9. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
    Limnell T, Santos HA, Mäkilä E, Heikkilä T, Salonen J, Murzin DY, Kumar N, Laaksonen T, Peltonen L, Hirvonen J.
    J Pharm Sci; 2011 Aug 23; 100(8):3294-3306. PubMed ID: 21520084
    [Abstract] [Full Text] [Related]

  • 10. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy.
    Monem AS, Elbialy N, Mohamed N.
    Int J Pharm; 2014 Aug 15; 470(1-2):1-7. PubMed ID: 24792973
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles.
    Limnell T, Heikkilä T, Santos HA, Sistonen S, Hellstén S, Laaksonen T, Peltonen L, Kumar N, Murzin DY, Louhi-Kultanen M, Salonen J, Hirvonen J, Lehto VP.
    Int J Pharm; 2011 Sep 15; 416(1):242-51. PubMed ID: 21763766
    [Abstract] [Full Text] [Related]

  • 15. Characterization and release kinetics study of potato starch nanocomposite films containing mesoporous nano-silica incorporated with Thyme essential oil.
    Cui Y, Cheng M, Han M, Zhang R, Wang X.
    Int J Biol Macromol; 2021 Aug 01; 184():566-573. PubMed ID: 34174300
    [Abstract] [Full Text] [Related]

  • 16. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H, Zhao Y, Liu J, Cui Y, Wang Y, Zhao Q, Wang S.
    Int J Pharm; 2016 Aug 20; 510(1):184-94. PubMed ID: 27262268
    [Abstract] [Full Text] [Related]

  • 17. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
    Charnay C, Bégu S, Tourné-Péteilh C, Nicole L, Lerner DA, Devoisselle JM.
    Eur J Pharm Biopharm; 2004 May 20; 57(3):533-40. PubMed ID: 15093603
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.